Bridging the Biotech Gap: TOSLA x Geltor 

While biotechnology is unlocking new frontiers in longevity and skin health, a massive gap remains: the formulation gap. At TOSLA, we specialize in crossing that divide. Our latest collaboration with Geltor marks a milestone in nutricosmetics: the launch of the Signaling Collagen Shot. 

From Lab Discovery to Daily Ritual 

The partnership combines Geltor’s protein design expertise with TOSLA’s mastery of liquid delivery systems. Together, we have moved PrimaColl® Type 21—the world’s first biodesigned, vegan signaling collagen—from a scientific possibility to a sensory reality. 

The Problem: The “Efficacy vs. Experience” Paradox 

Clinical efficacy alone doesn’t drive results; adherence does. If a supplement is inconvenient or unpalatable, the consumer won’t use it consistently enough to see the benefits. 

The Solution: The Liquid Imperative 

By utilizing our proprietary VELIOUS® Flavor Technology, we’ve transformed Geltor’s high-performance polypeptide into a smooth, Cherry-Raspberry liquid shot. 

• Precision Fermentation: vegan, biomimetic Type 21 collagen. 

• Clinically Backed: 80–92% of participants in clinical trials saw improved skin firmness and elasticity. 

• Optimized Delivery: Liquid formats ensure better absorption and easy habit formation. 

Why This Matters for the Nutricosmetic Market 

This collaboration is about a new model for innovation. We focus on the full system—optimizing stability, bioavailability, and daily usability so that brand partners can launch products that perform in the lab and delight in the kitchen. 

“TOSLA was built on the belief that efficacy alone is not enough—ritual drives results.” — Uroš Gotar, Chief Innovations Officer, TOSLA 

Experience the Future at Vitafoods & NYSCC 

We are bringing the future of ingestible beauty to the world’s biggest stages. Join us to taste the innovation for yourself: 

*PrimaColl® has FDA GRAS status, BUT is NOT currently authorized for use in food supplements in the European Union / United Kingdom and may require pre-market authorization in Canada.